Buy Aurobindo Pharma with a stop loss of 423: Ashwani Gujral
Aurobindo Pharma remains a buy with a stop of 423.
By 
| Updated:
| Updated: 
In a chat with ET Now, Ashwani Gujral, Fund Manager at ashwanigujral.com gives his stocks call.
ET Now: What are your stock recommendations?
Ashwani Gujral: Aurobindo Pharma remains a buy with a stop of 423, target of 445.
ET Now: What are your stock recommendations?
Ashwani Gujral: Aurobindo Pharma remains a buy with a stop of 423, target of 445.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
When Ashwani Gujral predicted current stock market selloff just a few days agoADVERTISEMENT
